Midnight MarketsV1.0
⚠ Not financial adviceNot financial advice. Independent research, not investment recommendations. The author and website make no representation as to accuracy or completeness. Do your own due diligence before acting on anything you read here. Read the full disclaimer →
The Bioprocessing Single-Use — Filters, Resins & Bioreactors · The GLP-1 & Bio Supply Chain — Peptides, Bioprocessing & Diagnostics

SRT.DE

Sartorius (parent) / Sartorius Stedim
Foreign listing — not directly tradable in a US brokerage. Editorial detail only.

European bioprocessing pure-play. ~20% global bioprocessing equipment share. Single-use bioreactor leader.

What they do

European bioprocessing pure-play. ~20% global bioprocessing equipment share; leader in single-use bioreactors . Q1 2026 sales €748M (+5%). Recovery from destocking is the multi-year setup. Premium valuation reflects quality and moat.